Invention Grant
US07659280B2 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
有权
用于治疗或预防自身免疫疾病的2,4-嘧啶二胺化合物
- Patent Title: 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
- Patent Title (中): 用于治疗或预防自身免疫疾病的2,4-嘧啶二胺化合物
-
Application No.: US11676096Application Date: 2007-02-16
-
Publication No.: US07659280B2Publication Date: 2010-02-09
- Inventor: Jeffrey Wayne Clough , Somasekhar Bhamidipati , Rajinder Singh , Esteban Masuda , Haoran Zhao
- Applicant: Jeffrey Wayne Clough , Somasekhar Bhamidipati , Rajinder Singh , Esteban Masuda , Haoran Zhao
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Klarquist Sparkman, LLP
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D411/12 ; C07D413/12 ; C07D417/12 ; A61K31/506 ; A61K31/535 ; A61K31/541 ; A61P19/02
Abstract:
The present invention provides 3-hydroxyphenyl-2,4-pyrimidinediamine compounds of formula I, as well as related compositions and methods for treating a variety of autoimmune diseases.
Public/Granted literature
- US20070197782A1 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES Public/Granted day:2007-08-23
Information query
